Scholars Central

Conference abstract

Link between diabetes and cognitive impairment

Authors: Naushira Pandya

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Clinical experience and multiple research studies suggest that persons with diabetes are more likely to develop cognitive impairment or frank dementia which may be Alzheimer?s type or vascular dementia. Initially this may be subtle and manifest itself as mental slowing or apathy. On the other hand, patients with Alzheimer?s disease have an increased risk of developing Type 2 diabetes. What both these groups have in common is advanced age, a genetic predisposition, and comparable pathological features in the pancreatic islets and the brain, namely amyloid derived from amyloid B protein in the brain of Alzheimer?s disease and islet amyloid derived from islet amyloid polypeptide in the pancreas in Type 2 diabetes. A study of subjects from the Mayo Clinic Alzheimer Disease Patient Registry found that both Type 2 Diabetes (35% vs. 18%; P<0.05), and impaired fasting glucose (46% vs. 24%; P<0.01) were more prevalent in Alzheimer disease versus non- Alzheimer disease control subjects. Hence 81% of cases of Alzheimer disease had either Type 2 diabetes or IFG. In selected subjects in whom autopsy data was available, islet cell amyloid was more frequent and extensive in patients with Alzheimer disease than the non-Alzheimer disease controls. However diffuse neuritic plaques were not more common in patients with Type 2 diabetes than in control subjects. The Honolulu-Asia aging study investigated the effects of brain aging in very old men of Japanese ?American descent born between 1900 and 1919 utilizing MRI. The prevalence of diabetes in this cohort was 38% and subjects with Type 2 diabetes had a moderately increased risk of lacunes (small brain infarcts) (odds ratio (OR)1.6) and atrophy of the hippocampus(OR 1.7). Those with a longer history of diabetes, those taking insulin and those with complications, had more common pathological changes commonly seen in dementia. The development of dementia and even depression will adversely affect overall health and diabetes management in particular. Managing complex medication regimens including multiple injections of insulin or glucagon-like peptide 1 agonists will become problematic and may result in severe hypo or hyperglycemia. Memory impairment, executive dysfunction and functional impairment that accompanied neurodegenerative processes will lead to poor food choices, and meal preparation, as well as difficulty in glucose monitoring.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Gerontology & Geriatric Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGerontology & Geriatric Research
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Naushira Pandya”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels